A phase I/II study of antroquinonol in combination with nab-paclitaxel and gemcitabine for patients with metastatic pancreatic cancer.

被引：0
|
作者：
Shan, Yan-Shen
Li, Chung-Pin
Khan, Gazala
Lee, Woo Jin
Choi, Hye Jin
Chang, Heung-Moon
Lee, Moon Hee
Wallmark, John M.
Chen, Pei-Ni
机构：
[1] NCKU & NCKUH, Coll Med, Tainan, Taiwan
[2] Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol, Taipei, Taiwan
[3] Henry Ford Hlth Syst, Detroit, MI USA
[4] Natl Canc Ctr, Res Inst & Hosp, Goyang, South Korea
[5] Yonsei Univ Hlth Syst, Severance Hosp, Seoul, South Korea
[6] Univ Ulsan, Asan Med Ctr, Coll Med, Seoul, South Korea
[7] Inha Univ, Dept Internal Med, Coll Med, Incheon, South Korea
[8] Associates Oncol Hematol PC, Rockville, MD USA
[9] Golden Biotechnol Corp, New Taipei City, Taiwan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 3_SUPPL期
关键词：
261-492-199-2823; 298-145-222-184-1022-9122; 283-2494; 261-492-2769; 298-145-222-184-1022-9124; 298-145-222-184-1022-8913; 283-237-267; 4; 3; 2; 219; 3618; 176; 12; 6; 1;
D O I：
10.1200/JCO.2024.42.3_suppl.648
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：648 / 648
页数：1
相关论文
共 50 条
  • [1] Phase I/II study of LDE225 in combination with gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer.
    Pijnappel, Esther N.
    Wassenaar, Nienke P. M.
    Gurney-Champion, Oliver J.
    Klaassen, Remy
    van der Lee, Koen S.
    Pleunis-van Empel, Marjolein
    Richel, Dick J.
    Legdeur, Marie-Cecile J. C.
    Nederveen, Aart J.
    Van Laarhoven, Hanneke W. M.
    Wilmink, Johanna
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [2] A Phase II study of weekly nab-paclitaxel in combination with gemcitabine in patients with metastatic breast cancer.
    Zhao, Yannan
    Lv, Fangfang
    Chen, Shen
    Lu, Yunhua
    Cao, Enying
    Wang, Zhonghua
    Zhang, Jian
    Zhang, Sheng
    Cao, Jun
    Zheng, Chunlei
    Wang, Leiping
    Wang, Biyun
    Hu, Xichun
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [3] Phase I/II Study of LDE225 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Cancer
    Pijnappel, Esther N.
    Wassenaar, Nienke P. M.
    Gurney-Champion, Oliver J.
    Klaassen, Remy
    van der Lee, Koen
    Pleunis-van Empel, Marjolein C. H.
    Richel, Dick J.
    Legdeur, Marie C.
    Nederveen, Aart J.
    van Laarhoven, Hanneke W. M.
    Wilmink, Johanna W.
    CANCERS, 2021, 13 (19)
  • [4] Phase I/II study of LDE225 in combination with gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer
    Pijnappel, E. N.
    Klaassen, R.
    van der Lee, K. S.
    Pleunis-van Empel, M.
    Richel, D.
    Legdeur, M.
    Nederveen, A.
    van Laarhoven, H. W. M.
    Wilmink, H. W.
    ANNALS OF ONCOLOGY, 2019, 30
  • [5] A phase II study of nab-paclitaxel and gemcitabine in Korean patients with metastatic pancreatic cancer
    Lee, S. J.
    Oh, D-Y.
    Kang, J-H.
    Choi, H. J.
    Lee, M. A.
    Oh, S. Y.
    Kim, S-T.
    Park, Y. S.
    Ryu, B-Y.
    Park, J. O.
    ANNALS OF ONCOLOGY, 2018, 29
  • [6] Phase I study of nab-paclitaxel and gemcitabine combination in patients with advanced pancreatic cancer
    Drengler, R. L.
    Smith, L. S.
    Wood, T. E.
    Borad, M. J.
    Ramanathan, R. K.
    Laheru, D. A.
    Hidalgo, M.
    Von Hoff, D. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] Phase II study of pirfenidone combined with nab-paclitaxel and gemcitabine for patients with metastatic pancreatic cancer
    Guo, Guifang
    Li, Shengping
    Mao, Yize
    Yang, Qiuxia
    Yao, Zehui
    Wang, Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [8] Phase Ib/II study of ALT-803 in combination with gemcitabine and nab-paclitaxel in patients with advanced pancreatic cancer.
    Acoba, Jared David
    Rock, Amy
    Wong, Hing C.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [9] Phase I trial of enzalutamide in combination with gemcitabine and nab-paclitaxel for the treatment of advanced pancreatic cancer.
    Mahipal, Amit
    Springett, Gregory M.
    Burke, Nancy
    Bertels, Barbara
    Wapinsky, Georgine
    Almhanna, Khaldoun
    Kim, Richard D.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [10] A phase I trial of nab-paclitaxel, gemcitabine, and capecitabine for metastatic pancreatic cancer
    Andrew H. Ko
    Thach-Giao Truong
    Emily Kantoff
    Kimberly A. Jones
    Elizabeth Dito
    Anna Ong
    Margaret A. Tempero
    Cancer Chemotherapy and Pharmacology, 2012, 70 : 875 - 881
12345